Roles of Ferric Peroxide Anion Intermediates (Fe3+O2-, Compound 0) in Cytochrome P450 19A1 Steroid Aromatization and a Cytochrome P450 2B4 Secosteroid Oxidation Model.

Cytochrome P450 Enzyme mechanism Mass spectrometry Steroid aromatase Steroid metabolism

Journal

Angewandte Chemie (International ed. in English)
ISSN: 1521-3773
Titre abrégé: Angew Chem Int Ed Engl
Pays: Germany
ID NLM: 0370543

Informations de publication

Date de publication:
31 May 2024
Historique:
revised: 28 05 2024
received: 06 04 2024
accepted: 30 05 2024
medline: 31 5 2024
pubmed: 31 5 2024
entrez: 31 5 2024
Statut: aheadofprint

Résumé

Cytochrome P450 (P450, CYP) 19A1 is the steroid aromatase, the enzyme responsible for the 3-step conversion of androgens (androstenedione or testosterone) to estrogens. The final step is C-C bond scission (removing the 19-oxo group as formic acid) that proceeds via a historically controversial reaction mechanism. The two competing mechanistic possibilities involve a ferric peroxide anion (Fe3+O2-, Compound 0) and a perferryl oxy species (FeO3+, Compound I). One approach to discern the role of each species in the reaction is with the use of oxygen-18 labeling, i.e., from 18O2 and H218O of the reaction product formic acid. We applied this approach, using several technical improvements, to study the deformylation of 19-oxo-androstenedione by human P450 19A1 and of a model secosteroid, 3-oxodecaline-4-ene-10-carboxaldehyde (ODEC), by rabbit P450 2B4. Both aldehyde substrates were sensitive to non-enzymatic acid-catalyzed deformylation, yielding 19-norsteroids, and conditions were established to avoid issues with artifactual generation of formic acid. The Compound 0 reaction pathway predominated (i.e., Fe3+O2-) in both P450 19A1 oxidation of 19-oxo-androstenedione and P450 2B4 oxidation of ODEC. The P450 19A1 results contrast with our prior conclusions (J. Am. Chem. Soc. 2014, 136, 15016-16025), attributed to several technical modifications.

Identifiants

pubmed: 38820076
doi: 10.1002/anie.202406542
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

e202406542

Informations de copyright

© 2024 Wiley‐VCH GmbH.

Auteurs

Yasuhiro Tateishi (Y)

Vanderbilt University School of Medicine, Biochemistry, 2200 Pierce Avenue, 642 Robinsons Research Building, 37232, Nashville, UNITED STATES.

Kevin D McCarty (KD)

Vanderbilt University School of Medicine, Biochemistry, 2200 Pierce Avenue, 642 Robinson Reasearch Building, 37232, Nashville, UNITED STATES.

Martha V Martin (MV)

Vanderbilt University School of Medicine, Biochemistry, 2200 Pierce Avenue, 642 Robinson Research Building, 37232, Nashville, UNITED STATES.

Francis K Yoshimoto (FK)

University of Texas at San Antonio, Chemistry, One UTSA Circle, 78249, San Antonio, UNITED STATES.

Frederick Peter Guengerich (FP)

Vanderbilt University School of Medicine, Department of Biochemistry, 2220 Pierce Avenue, 638B Robinson Research Building, 37232-0146, Nashville, UNITED STATES OF AMERICA.

Classifications MeSH